Business Description
Bolt Biotherapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US0977021049
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.05 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.18 | |||||
Debt-to-EBITDA | -0.27 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -3.39 | |||||
Beneish M-Score | -1.95 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 209.7 | |||||
3-Year EBITDA Growth Rate | -8.8 | |||||
3-Year EPS without NRI Growth Rate | -6 | |||||
3-Year FCF Growth Rate | -5.1 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 29.08 | |||||
9-Day RSI | 35.37 | |||||
14-Day RSI | 40.36 | |||||
6-1 Month Momentum % | 16.5 | |||||
12-1 Month Momentum % | -21.57 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.17 | |||||
Quick Ratio | 5.17 | |||||
Cash Ratio | 5 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.2 | |||||
Shareholder Yield % | 4.09 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -967.45 | |||||
Net Margin % | -878.58 | |||||
FCF Margin % | -885.36 | |||||
ROE % | -48.57 | |||||
ROA % | -36.05 | |||||
ROIC % | -112.92 | |||||
ROC (Joel Greenblatt) % | -290.02 | |||||
ROCE % | -44.11 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.29 | |||||
PB Ratio | 0.38 | |||||
Price-to-Tangible-Book | 0.38 | |||||
EV-to-EBIT | 0.52 | |||||
EV-to-EBITDA | 0.53 | |||||
EV-to-Revenue | -5.03 | |||||
EV-to-FCF | 0.57 | |||||
Price-to-Net-Current-Asset-Value | 0.72 | |||||
Price-to-Net-Cash | 0.77 | |||||
Earnings Yield (Greenblatt) % | 192.31 | |||||
FCF Yield % | -164.76 |